Brief: Starpharma Holdings Says Astrazeneca Has Made Decision To Discontinue Development Of Azd0466
31/07/2023 02:46
July 31 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* ASTRAZENECA HAS MADE DECISION TO DISCONTINUE DEVELOPMENT
OF
AZD0466, AFTER AN INTERNAL REVIEW
Source text for Eikon: ID:nASX3KtqMC
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising